- Home
- MRBK vs PLRX Comparison
MRBK vs PLRX Comparison
Compare MRBK & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- PLRX
- Stock Information
- Founded
- MRBK 2004
- PLRX 2015
- Country
- MRBK United States
- PLRX United States
- Employees
- MRBK N/A
- PLRX N/A
- Industry
- MRBK Major Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MRBK Finance
- PLRX Health Care
- Exchange
- MRBK Nasdaq
- PLRX Nasdaq
- Market Cap
- MRBK N/A
- PLRX 87.0M
- IPO Year
- MRBK 2017
- PLRX 2020
- Fundamental
- Price
- MRBK $13.25
- PLRX $1.46
- Analyst Decision
- MRBK Buy
- PLRX Hold
- Analyst Count
- MRBK 2
- PLRX 10
- Target Price
- MRBK $16.00
- PLRX $9.79
- AVG Volume (30 Days)
- MRBK 55.6K
- PLRX 1.4M
- Earning Date
- MRBK 04-29-2025
- PLRX 05-05-2025
- Dividend Yield
- MRBK 3.77%
- PLRX N/A
- EPS Growth
- MRBK 25.00
- PLRX N/A
- EPS
- MRBK 1.45
- PLRX N/A
- Revenue
- MRBK $100,935,000.00
- PLRX N/A
- Revenue This Year
- MRBK $22.20
- PLRX N/A
- Revenue Next Year
- MRBK $9.93
- PLRX N/A
- P/E Ratio
- MRBK $9.14
- PLRX N/A
- Revenue Growth
- MRBK 7.27
- PLRX N/A
- 52 Week Low
- MRBK $8.27
- PLRX $1.10
- 52 Week High
- MRBK $17.33
- PLRX $16.52
- Technical
- Relative Strength Index (RSI)
- MRBK 40.86
- PLRX 37.18
- Support Level
- MRBK $12.88
- PLRX $1.10
- Resistance Level
- MRBK $14.13
- PLRX $1.34
- Average True Range (ATR)
- MRBK 0.81
- PLRX 0.12
- MACD
- MRBK 0.03
- PLRX 0.15
- Stochastic Oscillator
- MRBK 43.81
- PLRX 88.45
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.